Tamman, Hedvig https://orcid.org/0000-0003-4453-7814
Ernits, Karin
Roghanian, Mohammad https://orcid.org/0000-0003-3116-3817
Ainelo, Andres
Julius, Christina
Perrier, Anthony https://orcid.org/0000-0002-4473-3711
Talavera, Ariel https://orcid.org/0000-0002-1865-5959
Ainelo, Hanna
Dugauquier, Rémy https://orcid.org/0000-0002-9662-8905
Zedek, Safia
Thureau, Aurelien https://orcid.org/0000-0001-5666-260X
Pérez, Javier https://orcid.org/0000-0003-3083-4754
Lima-Mendez, Gipsi https://orcid.org/0000-0002-5309-1845
Hallez, Régis https://orcid.org/0000-0003-1175-8565
Atkinson, Gemma C. https://orcid.org/0000-0002-4861-4584
Hauryliuk, Vasili https://orcid.org/0000-0003-2389-5057
Garcia-Pino, Abel https://orcid.org/0000-0002-0634-0300
Article History
Received: 24 January 2022
Accepted: 5 October 2022
First Online: 5 December 2022
Competing interests
: A.G.-P. is cofounder and stockholder of Santero Therapeutics, a company that aims to develop inventions described in this paper. The other authors declare no competing interests.